Regulatory Guidance on Home Delivery of Investigational Products (IP) in Clinical Trials
Regulatory Guidance on Home Delivery of Investigational Products (IP) in Clinical Trials Navigating Regulatory Guidance for Home Delivery of Investigational Products in DCTs Direct-to-Patient (DTP) drug delivery is a growing practice in decentralized clinical trials (DCTs), enabling investigational products (IP) to reach participants at their homes. This model has transformed clinical trial accessibility but also…